IL131543A - Cosmetic methods and compositions for preventing and treating chronological aging in human skin - Google Patents

Cosmetic methods and compositions for preventing and treating chronological aging in human skin

Info

Publication number
IL131543A
IL131543A IL13154398A IL13154398A IL131543A IL 131543 A IL131543 A IL 131543A IL 13154398 A IL13154398 A IL 13154398A IL 13154398 A IL13154398 A IL 13154398A IL 131543 A IL131543 A IL 131543A
Authority
IL
Israel
Prior art keywords
compositions
preventing
human skin
chronological aging
cosmetic methods
Prior art date
Application number
IL13154398A
Other languages
English (en)
Other versions
IL131543A0 (en
Original Assignee
Univ Michigan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26717212&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL131543(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Michigan filed Critical Univ Michigan
Publication of IL131543A0 publication Critical patent/IL131543A0/xx
Publication of IL131543A publication Critical patent/IL131543A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/671Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42Amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63Steroids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74Biological properties of particular ingredients
    • A61K2800/78Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Emergency Medicine (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
IL13154398A 1997-02-25 1998-02-23 Cosmetic methods and compositions for preventing and treating chronological aging in human skin IL131543A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4059497P 1997-02-25 1997-02-25
US4297697P 1997-04-08 1997-04-08
PCT/US1998/003743 WO1998036742A1 (fr) 1997-02-25 1998-02-23 Procedes et compositions servant a prevenir et a traiter un viellissement de la peau humaine du a l'age

Publications (2)

Publication Number Publication Date
IL131543A0 IL131543A0 (en) 2001-01-28
IL131543A true IL131543A (en) 2005-08-31

Family

ID=26717212

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13154398A IL131543A (en) 1997-02-25 1998-02-23 Cosmetic methods and compositions for preventing and treating chronological aging in human skin

Country Status (10)

Country Link
US (2) US6630516B2 (fr)
EP (1) EP1005333B1 (fr)
JP (2) JP2002515898A (fr)
CN (1) CN100360121C (fr)
AU (1) AU737376B2 (fr)
BR (1) BR9807854A (fr)
CA (1) CA2281944C (fr)
DE (1) DE69828620T2 (fr)
IL (1) IL131543A (fr)
WO (1) WO1998036742A1 (fr)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998036742A1 (fr) * 1997-02-25 1998-08-27 The Regents Of The University Of Michigan Procedes et compositions servant a prevenir et a traiter un viellissement de la peau humaine du a l'age
US20040131579A1 (en) * 1998-09-10 2004-07-08 Avon Products, Inc. Method and compositions for reducing dermatological aging and for reducing bruising
US6887260B1 (en) 1998-11-30 2005-05-03 Light Bioscience, Llc Method and apparatus for acne treatment
US9192780B2 (en) 1998-11-30 2015-11-24 L'oreal Low intensity light therapy for treatment of retinal, macular, and visual pathway disorders
US6283956B1 (en) 1998-11-30 2001-09-04 David H. McDaniels Reduction, elimination, or stimulation of hair growth
US20060212025A1 (en) 1998-11-30 2006-09-21 Light Bioscience, Llc Method and apparatus for acne treatment
MXPA02004933A (es) * 1999-11-16 2004-08-12 Unilever Nv Composiciones cosmeticas conteniendo extracto de garbanzo y retinoides.
US7977385B2 (en) * 2000-03-02 2011-07-12 Numoda Biotechnologies, Inc. Agents for corneal or intrastromal administration to treat or prevent disorders of the eye
US20030199574A1 (en) * 2000-03-02 2003-10-23 Vitreo-Retinal Technologies, Inc. Treatment of ophthalmic disorders using urea and urea derivatives
EP1261314A4 (fr) * 2000-03-07 2003-06-11 Avon Prod Inc Methodes utilisant du phytol destinees a l'amelioration de l'apparence de la peau et compositions correspondantes
EP1267813A2 (fr) * 2000-03-31 2003-01-02 Henkel Kommanditgesellschaft auf Aktien Utilisation d'inhibiteurs de protease dans les cosmetiques et produits pharmaceutiques
JP2002047125A (ja) * 2000-05-26 2002-02-12 Shiseido Co Ltd 皮脂分泌抑制用皮膚外用剤
EP1294349A2 (fr) * 2000-06-26 2003-03-26 The Regents Of The University Of Michigan Utilisation d'inhibiteurs de proteine tyrosine kinase du recepteur de facteur de croissance epidermique (egf-r) pour la prevention du photovieillissement de la peau humaine
US20040185127A1 (en) * 2001-06-29 2004-09-23 Lerner David S. Cosmetic composition and method
FR2811561B1 (fr) * 2000-07-13 2003-03-21 Oreal Composition, notamment cosmetique, renfermant la dhea et/ou un precurseur ou derive chimique ou biologique de celle-ci, et un inhibiteur de metalloproteinase
FR2823117A1 (fr) * 2000-11-14 2002-10-11 Pharmascience Lab Composition pharmaceutique ou cosmetique ainsi que l'utilisation d'au moins un compose actif pour inhiber la migration des cellules de langerhans
US20020119107A1 (en) * 2000-12-18 2002-08-29 James Varani Method for protecting and restoring skin using selective MMP inhibitors
US6734858B2 (en) * 2000-12-27 2004-05-11 Avon Products, Inc. Method and apparatus for use of computer aging to demonstrate a product benefit
DE10102784A1 (de) * 2001-01-22 2002-08-01 Henkel Kgaa Kosmetische oder pharmazeutische Zubereitungen zur Behandlung epithelialen Deckgewebes
JP2002284678A (ja) * 2001-03-23 2002-10-03 Ajinomoto Co Inc 皮膚外用剤
US7713942B2 (en) * 2001-04-04 2010-05-11 Nordic Vaccine Technology A/S Cage-like microparticle complexes comprising sterols and saponins for delivery of polynucleotides
FR2826266B1 (fr) * 2001-06-26 2005-02-25 Oreal Composition cosmetique ou dermatologique comprenant une association entre un compose de la famille des n-acylaminoamides et au moins un inhibiteur de metalloproteinases matricielles
US20030083321A1 (en) * 2001-09-25 2003-05-01 Lerner David S. Composition and method for minimizing or avoiding adverse effects of vesicants
EP1297830A1 (fr) * 2001-09-28 2003-04-02 Flamma Fabbrica Lombarda Ammino Acidi S.p.a. L'utilisation des acides aminés alpha ou bèta, leurs esters, ou de dipeptides de ces acides aminés avec des dérivés d'histidine, dans la prévention ou le traitement de lésions de la peau causées par l'ozone atmosphérique
US7354956B2 (en) 2002-04-12 2008-04-08 L'oreal Composition containing a sapogenin and use thereof
US20040033246A1 (en) * 2002-06-25 2004-02-19 Kose Corporation Cosmetic for prevention of skin aging and agent for prevention of skin aging
FR2847269B1 (fr) * 2002-11-19 2006-07-28 Coletica Procede d'identification d'une modification eventuelle d'au moins un parametre biologique mettant en oeuvre des cellules vivantes jeunes et agees
AU2003300076C1 (en) 2002-12-30 2010-03-04 Angiotech International Ag Drug delivery from rapid gelling polymer composition
WO2004092335A2 (fr) * 2003-04-10 2004-10-28 Light Bioscience, Inc. Procedes de photomodulation et dispositifs de regulation de la proliferation cellulaire et de l'expression genetique
KR101160343B1 (ko) * 2003-07-31 2012-06-26 젠틀웨이브즈 엘엘씨. 화상, 상처 및 관련 피부 질환의 광역학적 치료 장치 및방법
EP1660437B1 (fr) * 2003-08-26 2008-10-15 Amorepacific Corporation Derives d'acide hydroxamique et leur methode de preparation
WO2006053415A1 (fr) * 2004-11-18 2006-05-26 Biopharmacopae Design International Inc. Extraits de plantes et leurs utilisations en dermatologie
US20070248574A1 (en) * 2004-01-27 2007-10-25 Miller Freda D Methods of Making and Using Skin-Derived Stem Cells
US20090143458A1 (en) * 2004-01-30 2009-06-04 Ace Aps Use of ace inhibitors and/or angiostensin ii receptor antagonists for the improving and/or maintaining the skin tone and for the treatment of skin ageing
ES2363978T3 (es) * 2004-02-13 2011-08-22 Cognis France, S.A.S. Uso de composiciones cosméticas que comprenden un extracto de las hojas de castanea sativa.
US20050202055A1 (en) 2004-03-11 2005-09-15 Koichi Shudo, Tokyo, Japan Anti-wrinkle agent
DK2233127T3 (da) 2004-03-17 2020-08-24 Stada Arzneimittel Ag Anvendelse af antioxidanter til fremstilling af en farmaceutisk eller kosmetisk sammensætning for at beskytte huden mod skader som følge af infrarød stråling
US20080227868A1 (en) 2004-03-26 2008-09-18 Volker Schehlmann Composition Comprising an Hdac Inhibitor in Combination with a Retinoid
ZA200804907B (en) * 2004-08-18 2009-04-29 Ace Aps Cosmetic and pharmaceutical compositions comprising ACE inhibitors and/or angiotensin II receptor antagonists
JP4777738B2 (ja) * 2004-10-14 2011-09-21 株式会社 資生堂 Adam活性阻害物質によるしわの防止または改善
FR2877220B1 (fr) * 2004-11-04 2008-10-10 Oreal Utilisation de composes d'uree pour lutter contre les signes du vieillissement cutane
US8173144B2 (en) * 2004-11-04 2012-05-08 L'oreal Administration of urea compounds for combating signs of cutaneous aging
US20060265030A1 (en) * 2004-11-12 2006-11-23 Light Bioscience, Llc System and method for photodynamic cell therapy
US20060165641A1 (en) * 2005-01-18 2006-07-27 Kumar Pillai Cosmetic compositions containing combinations of hydroxamate derivatives and antioxidants in a liposomal delivery system
JP4526971B2 (ja) * 2005-02-14 2010-08-18 株式会社資生堂 フィブュリン−5を指標とした皮膚老化状態の評価方法
US8278359B2 (en) * 2005-02-25 2012-10-02 Johnson & Johnson Consumer Companies, Inc. Compositions containing amines and use thereof to treat acne or reduce the appearance of oil or pores on the skin
US8221046B2 (en) 2005-02-25 2012-07-17 Johnson & Johnson Consumer Companies, Inc. Compositions containing amines and use thereof
US20060193814A1 (en) 2005-02-25 2006-08-31 Eduardo Ruvolo Compositions for the treatment of signs of aging
US20060275229A1 (en) * 2005-05-17 2006-12-07 Sreekumar Pillai Skin care active complex and methods of using same
EP1837392A1 (fr) 2006-03-21 2007-09-26 Chanel Parfums Beauté Huile de magnolia champaca, son procédé d'obtention, et compositions la contenant
WO2007134219A2 (fr) * 2006-05-11 2007-11-22 Living Proof, Inc. Polymérisation in situ pour le traitement de la peau
US8987212B2 (en) 2007-08-07 2015-03-24 Muhammed Majeed Oleanoyl peptide composition and method of treating skin aging
ES2330291B1 (es) 2008-02-29 2010-10-18 Lipotec Sa Peptidos utiles en el tratamiento de la piel, mucosas y/o cuero cabelludo y su uso en composiciones cosmeticas o farmaceuticas.
CA2757342C (fr) * 2008-04-01 2017-05-09 Biopharmacopae Design International Inc. Extraits de plantes du genre tsuga et utilisations de ceux-ci dans le traitement de l'inflammation, de l'irritation et/ou de l'infection
WO2009127248A1 (fr) 2008-04-16 2009-10-22 United Technologies Ut Ag Compositions cosmétiques et dermatologiques contenant de l'interleukine-1 alpha
US20100173024A1 (en) * 2008-12-01 2010-07-08 LifeSpan Extension, LLC Methods and compositions for altering health, wellbeing, and lifespan
RU2765463C2 (ru) * 2008-12-04 2022-01-31 Чунси ЮЙ Композиции интенсивного проникновения и их применение
ES2349972B1 (es) 2009-02-16 2011-11-24 Lipotec, S.A. Péptidos útiles en el tratamiento y/o cuidado de la piel, mucosas y/o cuero cabelludo y su uso en composiciones cosméticas o farmacéuticas.
WO2011135341A2 (fr) * 2010-04-26 2011-11-03 Ame Health Ltd Établissement de profils de peau et son utilisation dans l'essai de produits cosmétiques
EP2575456B1 (fr) * 2010-05-28 2016-05-04 Galderma S.A. Compositions et procédés destinés au traitement d'ecchymoses
WO2016126343A1 (fr) 2015-02-05 2016-08-11 Muhammed Majeed Composition de peptide d'oléanoyle et augmentation du collagène
US9216209B1 (en) 2011-06-06 2015-12-22 Kilmer S. McCully Compositions and method for utilization of thioretinamide in therapy of degenerative diseases of aging
US10639252B2 (en) 2011-09-23 2020-05-05 Allergan, Inc. Compositions for skin exfoliation and use thereof
MY172154A (en) * 2012-08-29 2019-11-14 Biotropics Malaysia Berhad Composition for cognition and cosmetic purposes and use of said composition for preparing an agent
ES2896354T3 (es) 2012-12-21 2022-02-24 Astellas Inst For Regenerative Medicine Métodos para la producción de plaquetas a partir de células madre pluripotentes
FR3006191B1 (fr) * 2013-06-03 2016-04-29 Pierre Fabre Dermo-Cosmetique Compositions cosmetiques ou dermatologiques associant du retinaldehyde et de l'oleamide de glycylglycine, et leurs utilisations en cosmetique ou dermatologie
GB201502268D0 (en) 2015-02-11 2015-04-01 Calscience Internat Ltd Dental composition and use
JP2016222621A (ja) * 2015-06-02 2016-12-28 学校法人九州文化学園 メラニン合成促進組成物
JP2017210442A (ja) * 2016-05-26 2017-11-30 イノレックス インベストメント コーポレイション マトリックスメタロプロテイナーゼを阻害して皮膚の老化を軽減する方法及び関連の相乗的組成物
EP3656867A1 (fr) * 2017-07-18 2020-05-27 Shiseido Company, Ltd. Procédé de criblage de substances anti-âge
JP2018168177A (ja) * 2018-07-03 2018-11-01 イノレックス インベストメント コーポレイション マトリックスメタロプロテイナーゼを阻害して皮膚の老化を軽減する方法及び関連の相乗的組成物
CN113144192A (zh) * 2020-01-22 2021-07-23 中国科学院上海营养与健康研究所 Mapk/erk通路抑制剂在拮抗皮肤老化与辐射性皮肤早衰中的应用
WO2022128057A1 (fr) 2020-12-14 2022-06-23 Symrise Ag Médicament pour la prévention et le traitement de la dégradation du collagène dans un tissu conjonctif humain

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4603146A (en) * 1984-05-16 1986-07-29 Kligman Albert M Methods for retarding the effects of aging of the skin
US4666897A (en) * 1983-12-29 1987-05-19 Research Foundation Of State University Inhibition of mammalian collagenolytic enzymes by tetracyclines
US4888342A (en) * 1984-05-16 1989-12-19 Kligman Albert M Methods for treatment of sundamaged human skin with retinoids
US5091171B2 (en) * 1986-12-23 1997-07-15 Tristrata Inc Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use
GB8827305D0 (en) * 1988-11-23 1988-12-29 British Bio Technology Compounds
AU636595B2 (en) * 1989-01-19 1993-05-06 Ortho Pharmaceutical Corporation Method for the treatment or prevention of intrinsically aged skin with retinoids
US5093360A (en) * 1989-04-07 1992-03-03 Yu Ruey J Retinal, derivatives and their therapeutic use
US5308839A (en) * 1989-12-04 1994-05-03 The Research Foundation Of State University Of New York Composition comprising non-steroidal anti-inflammatory agent tenidap and effectively non-antibacterial tetracycline
LU87843A1 (fr) * 1990-11-15 1992-08-25 Cird Galderma Gel aqueux a base d'acide retinoique et d'hydroxypropyl-beta-cyclodextrine et son utilisation en medecine humaine et en cosmetique
US5189178A (en) * 1990-11-21 1993-02-23 Galardy Richard E Matrix metalloprotease inhibitors
US5239078A (en) * 1990-11-21 1993-08-24 Glycomed Incorporated Matrix metalloprotease inhibitors
GB9102635D0 (en) * 1991-02-07 1991-03-27 British Bio Technology Compounds
JP3818674B2 (ja) * 1992-06-02 2006-09-06 三省製薬株式会社 皮膚外用剤
US5310759A (en) * 1992-08-12 1994-05-10 Bockman Richard S Methods of protecting and preserving connective and support tissues
JP3277033B2 (ja) * 1993-06-17 2002-04-22 カネボウ株式会社 化粧料
WO1995007924A1 (fr) * 1993-09-17 1995-03-23 Andy Shih Compositions a base de ribozymes pour la modification des phenotypes cutanes associes au vieillissement de la peau et des cheveux et a d'autres de leurs etats
FR2710839B1 (fr) * 1993-10-08 1995-12-08 Rocher Yves Biolog Vegetale Composition cosmétique et méthode de traitement esthétique s'opposant au vieillissement de la peau.
GB9405076D0 (en) * 1994-03-16 1994-04-27 Inst Of Ophtalmology A medical use of matrix metalloproteinase inhibitors
FR2717389B1 (fr) 1994-03-18 1996-06-07 Lvmh Rech Utilisation du ginsénoside Ro ou d'un extrait végétal en contenant pour stimuler la synthèse du collagène.
FR2718022B1 (fr) * 1994-04-01 1996-04-26 Roussel Uclaf Compositions cosmétiques ou dermatologiques et leur préparation.
FR2724317B1 (fr) * 1994-09-08 1996-10-18 Oreal Chelateurs de metaux photoclivables et compositions les contenant
US5476661A (en) * 1994-10-21 1995-12-19 Elizabeth Arden Co., Division Of Conopco, Inc. Compositions for topical application to skin, hair and nails
US5614489A (en) * 1995-05-25 1997-03-25 Mohammadi; Fatemeh Method and composition for treating the skin
JP3911642B2 (ja) * 1995-06-06 2007-05-09 株式会社加美乃素本舗 皮膚外用剤
US5837224A (en) * 1996-01-19 1998-11-17 The Regents Of The University Of Michigan Method of inhibiting photoaging of skin
AU2735297A (en) * 1996-04-18 1997-11-19 Geron Corporation Senescence responsive transcriptional element
SG70009A1 (en) * 1996-05-23 2000-01-25 Hoffmann La Roche Vitamin d3 analogs
WO1998036742A1 (fr) * 1997-02-25 1998-08-27 The Regents Of The University Of Michigan Procedes et compositions servant a prevenir et a traiter un viellissement de la peau humaine du a l'age
TWI234467B (en) * 1997-06-04 2005-06-21 Univ Michigan Composition for inhibiting photoaging of skin

Also Published As

Publication number Publication date
WO1998036742A1 (fr) 1998-08-27
JP2002515898A (ja) 2002-05-28
AU737376B2 (en) 2001-08-16
US20010053347A1 (en) 2001-12-20
CA2281944A1 (fr) 1998-08-27
US20040034098A1 (en) 2004-02-19
CN1251989A (zh) 2000-05-03
DE69828620T2 (de) 2005-12-01
BR9807854A (pt) 2000-02-22
AU6537498A (en) 1998-09-09
JP2010195817A (ja) 2010-09-09
IL131543A0 (en) 2001-01-28
CA2281944C (fr) 2007-05-15
EP1005333A4 (fr) 2001-03-14
EP1005333B1 (fr) 2005-01-12
DE69828620D1 (de) 2005-02-17
US6919072B2 (en) 2005-07-19
US6630516B2 (en) 2003-10-07
EP1005333A1 (fr) 2000-06-07
CN100360121C (zh) 2008-01-09

Similar Documents

Publication Publication Date Title
IL131543A0 (en) Cosmetic methods and compositions for preventing and treating chronological aging in human skin
EP0946158A4 (fr) Compositions et procede de bronzage de la peau
HUP9904677A3 (en) Cosmetic composition for skin care
EP0796077A4 (fr) Composition de maquillage revitalisante
ZA947138B (en) Skin care method and composition
PL332542A1 (en) Skin care compositions containing amide and retinoide
PL332547A1 (en) Skin care compositions containing an acid and retinoide
HUP0004685A3 (en) Cleanser composition for skin and hair care
HUP9904637A3 (en) Shampoo composition and method of conditioning hair and/or skin
EP0687467A3 (fr) Préparations cosmétiques et dermatologiques contenant des éthers de glycerylalkyl comme composant actif
GB9801191D0 (en) Skin and hair darkening composition
HUP0002484A3 (en) Methods for improving the health of hair and scalp
AU5774699A (en) Human stearoyl-coa desaturase-related compositions and methods for treating skin disorders
IL111554A (en) Methods and compositions for hair treatment
GB9217444D0 (en) Compounds compositions and methods for producing pigmentation in hair or skin
PL324929A1 (en) Cosmetic method of treating and preventing the symptoms of skin ageing
GB9420224D0 (en) Cosmetic composition and beauty treatment method counteracting skin ageing
EP0835092A4 (fr) Composition et traitement pour la lutte contre la calvitie
EP0964673A4 (fr) Agents de protection de la peau et des cheveux
GB2321644B (en) Cosmetic composition for the treatment of the hair and/or the body
ZA947145B (en) Skin care method and composition
IL111228A0 (en) Non-invasive device and method for quantitative determination of oxidants and/or antioxidants in the skin
AU3887399A (en) Hair and skin treatment method and composition
GB9614958D0 (en) Cosmetic skin treatment and apparatus therefor
GB9822401D0 (en) Device for use in treatment of hair

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired